These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo]. Hu LD; Tang X; Cui FD Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775 [TBL] [Abstract][Full Text] [Related]
7. Physicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systems. Kawaguchi E; Shimokawa K; Ishii F Colloids Surf B Biointerfaces; 2008 Mar; 62(1):130-5. PubMed ID: 17988839 [TBL] [Abstract][Full Text] [Related]
8. Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions. Ishii F; Sasaki I; Ogata H J Pharm Pharmacol; 1990 Jul; 42(7):513-5. PubMed ID: 1980297 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice. Chansri N; Kawakami S; Yamashita F; Hashida M Int J Pharm; 2006 Sep; 321(1-2):42-9. PubMed ID: 16790329 [TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles. Kupetz E; Bunjes H J Control Release; 2014 Sep; 189():54-64. PubMed ID: 24933601 [TBL] [Abstract][Full Text] [Related]
12. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Yamaguchi M; Yasueda S; Isowaki A; Yamamoto M; Kimura M; Inada K; Ohtori A Int J Pharm; 2005 Sep; 301(1-2):121-8. PubMed ID: 16023810 [TBL] [Abstract][Full Text] [Related]
13. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Hwang SR; Lim SJ; Park JS; Kim CK Int J Pharm; 2004 May; 276(1-2):175-83. PubMed ID: 15113624 [TBL] [Abstract][Full Text] [Related]
14. Development of Clotrimazole Multiple W/O/W Emulsions as Vehicles for Drug Delivery: Effects of Additives on Emulsion Stability. Suñer J; Calpena AC; Clares B; Cañadas C; Halbaut L AAPS PharmSciTech; 2017 Feb; 18(2):539-550. PubMed ID: 27126008 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the pharmacokinetics of all-trans-retinoic acid (ATRA) in Wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell lines. Su J; Zhang N; Ho PC J Pharm Sci; 2008 Jul; 97(7):2844-53. PubMed ID: 17879972 [TBL] [Abstract][Full Text] [Related]
17. Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol. Shao Y; Zhang C; Yao Q; Wang Y; Tian B; Tang X; Wang Y Eur J Pharm Sci; 2014 Feb; 52():1-11. PubMed ID: 24153395 [TBL] [Abstract][Full Text] [Related]
18. Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions. Sakaeda T; Hirano K J Drug Target; 1998; 6(4):273-84. PubMed ID: 9894695 [TBL] [Abstract][Full Text] [Related]
19. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. Wang JJ; Sung KC; Hu OY; Yeh CH; Fang JY J Control Release; 2006 Oct; 115(2):140-9. PubMed ID: 16959357 [TBL] [Abstract][Full Text] [Related]
20. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation. Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]